Stockholm3 - A new option to detect Prostate Cancer
Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-t...
Main Authors: | Moosa Zulfiqar Ali, Roshaan Ahmad, Amna Akmal |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2022-04-01
|
Series: | Journal of the Pakistan Medical Association |
Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5109 |
Similar Items
-
The cost-effectiveness of prostate cancer screening using the Stockholm3 test.
by: Andreas A Karlsson, et al.
Published: (2021-01-01) -
Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
by: Joel Andersson, et al.
Published: (2022-10-01) -
Ethnic variation in prostate cancer detection: A hypothesis generating study for use of the Stockholm3 test in an American cohort
by: H.T. Vigneswaran, et al.
Published: (2020-07-01) -
Climate Change – A monumental risk to Pakistani health.
by: Moosa Zulfiqar Ali, et al.
Published: (2022-02-01) -
Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
by: Tushar Aditya Narain, et al.
Published: (2022-01-01)